PuSH - Publikationsserver des Helmholtz Zentrums München

Hornung, S.* ; Vogl, D.P.* ; Naltsas, D.* ; Dalla Volta, B.* ; Ballmann, M.* ; Marcon, B.* ; Syed, M.M.K.* ; Wu, Y.* ; Spanopoulou, A.* ; Feederle, R. ; Heidrich, L.* ; Bernhagen, J.* ; Koeglsperger, T.* ; Höglinger, G.U.* ; Rammes, G.* ; Lashuel, H.A.* ; Kapurniotu, A.*

Multi-targeting macrocyclic peptides as nanomolar inhibitors of self- and cross-seeded amyloid self-assembly of α-synuclein.

Angew. Chem.-Int. Edit.:e202422834 (2025)
Verlagsversion Forschungsdaten DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
Amyloid self-assembly of α-synuclein (αSyn) is linked to the pathogenesis of Parkinson's disease (PD). Type 2 diabetes (T2D) has recently emerged as a risk factor for PD. Cross-interactions between their amyloidogenic proteins may act as molecular links. In fact, fibrils of islet amyloid polypeptide (IAPP) (T2D) can cross-seed αSyn amyloidogenesis and αSyn and IAPP colocalize in PD brains. Inhibition of both self- and IAPP-cross-seeded αSyn amyloidogenesis could thus interfere with PD pathogenesis. Here we show that macrocyclic peptides, designed to mimic IAPP self-/cross-interaction sites and previously found to inhibit amyloidogenesis of IAPP and/or Alzheimer's disease (AD) amyloid-β peptide Aβ40(42), are nanomolar inhibitors of both self- and IAPP-cross-seeded amyloid self-assembly of αSyn. Anti-amyloid function is mediated by nanomolar affinity interactions with αSyn via three αSyn regions which are identified as key sites of both αSyn self-assembly and its cross-interactions with IAPP. We also show that the peptides block Aβ42-mediated cross-seeding of αSyn as well. Based on their broad spectrum anti-amyloid function and additional drug-like features, these peptides are leads for multifunctional anti-amyloid drugs in PD, T2D, AD, and their comorbidities, while the identified αSyn key segments are valuable targets for novel, multi-site targeting amyloid inhibitors in PD and related synucleinopathies.
Impact Factor
Scopus SNIP
Altmetric
16.900
0.000
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter (cross-)seeding ; Protein-protein Interactions ; Self-assembly ; A-synuclein ; Amyloid Inhibitor; A-beta; Parkinsons-disease; Designed Peptides; Iapp; Aggregation; Protein; Toxicity; Polypeptide; Oligomers; Regions
Sprache englisch
Veröffentlichungsjahr 2025
HGF-Berichtsjahr 2025
ISSN (print) / ISBN 1433-7851
e-ISSN 1521-3773
Quellenangaben Band: , Heft: , Seiten: , Artikelnummer: e202422834 Supplement: ,
Verlag Wiley
Verlagsort Weinheim
Begutachtungsstatus Peer reviewed
Institut(e) CF Monoclonal Antibodies (CF-MAB)
POF Topic(s) 30201 - Metabolic Health
PSP-Element(e) A-631900-001
Förderungen Deutsche Forschungsgemeinschaft
Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)
DFG under Germany's Excellence Strategy within the framework of the Munich Cluster for Systems Neurology
JPND Consortium, SynOD ,,alpha-Synuclein OMICS - Federal Ministry of Education and Research, BMBF
Studienstiftung des Deutschen Volkes e. V
PubMed ID 39822034
Erfassungsdatum 2025-03-20